Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universiti Tunku Abdul Rahman
This is a new attempt to evaluate the effectiveness of OneDoc PicopulseTM in treating melasma among women of childbearing age in Klang Valley, Malaysia. This pilot feasibility study protocol is to access feasibility of the OneDoc Picopulse™ in the future definitive trial. The findings of this study would justify OneDoc Picopulse™ as one of the promising alternative treatment for melasma.
Age
18–65
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women presenting dermal melasma with Fritzpatrick skin type III to V
Malaysian citizen
Agreed to participate
Provide informed consent
You may not be if
Patients who had a laser procedure, phototherapy therapy, peel, oral therapy, topical treatment or used lightening creams in the treatment area within the past 6 months.
Patients with pregnancy, lactating, active dermatitis, had a history of immunosuppression/immune deficiency disorders
Patients who photosensitivity or taking drugs known to induce photosensitivity,
Patients that have been exposed to severe sun exposure, having severe epidermal injury, allergy and sensitivity
Patients who could not attend follow-up treatments
Clareo Health | OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
